In focus
Latest feed
Eli Lilly's Zepbound Gets a Significant Price Drop: What It Means for Patients and the Market
Novo Nordisk's Alzheimer's Trial: A Minor Blip for a Pharma Giant
A Glimmer of Hope? Novo Nordisk's GLP-1 Drug and the Alzheimer's Enigma
The Billion-Dollar Standoff: Pfizer Unleashes on Novo Nordisk in Metsera Bid Battle
